These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25016397)

  • 21. Phenotypic characteristics of resistant hypertension in the Brazilian population.
    Faria AP; Sabbatini AR; Coca A; Moreno H
    Arq Bras Cardiol; 2013 Jun; 100(6):579-82. PubMed ID: 23657267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and clinical profile of resistant hypertension among treated hypertensive subjects.
    Barochiner J; Alfie J; Aparicio LS; Cuffaro PE; Rada MA; Morales MS; Galarza CR; Waisman GD
    Clin Exp Hypertens; 2013; 35(6):412-7. PubMed ID: 23148480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of blood pressure in patients with treatment-resistant hypertension.
    Acelajado MC; Calhoun DA; Oparil S
    Expert Opin Pharmacother; 2009 Dec; 10(18):2959-71. PubMed ID: 19925047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Definition, identification and treatment of resistant hypertension in chronic kidney disease patients.
    Drexler YR; Bomback AS
    Nephrol Dial Transplant; 2014 Jul; 29(7):1327-35. PubMed ID: 24046194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology of resistant hypertension.
    Sarafidis PA
    J Clin Hypertens (Greenwich); 2011 Jul; 13(7):523-8. PubMed ID: 21762366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study.
    Mielke J; Trucks-Jansen H; Schurmann C; Kotsis F; Köttgen A; Schneider MP; Eckardt KU; ; Freitag DF; Eitner F; Becker MS
    J Hum Hypertens; 2023 May; 37(5):345-353. PubMed ID: 35534618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug Development for Hypertension: Do We Need Another Antihypertensive Agent for Resistant Hypertension?
    Pimenta E; Calhoun DA
    Curr Hypertens Rep; 2016 Apr; 18(4):25. PubMed ID: 26949263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uncontrolled hypertension based on morning and evening home blood pressure measurements from the J-HOME study.
    Obara T; Ito K; Ohkubo T; Shibamiya T; Shinki T; Nakashita M; Hara A; Metoki H; Inoue R; Asayama K; Kikuya M; Mano N; Imai Y;
    Hypertens Res; 2009 Dec; 32(12):1072-8. PubMed ID: 19779486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical situations associated with difficult-to-control hypertension.
    Oliveras A; Schmieder RE
    J Hypertens; 2013 Mar; 31 Suppl 1():S3-8. PubMed ID: 23389084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.
    Bangalore S; Fayyad R; Laskey R; Demicco DA; Deedwania P; Kostis JB; Messerli FH;
    Am J Med; 2014 Jan; 127(1):71-81.e1. PubMed ID: 24210549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sleep apnea syndrome -- cause of resistance to treatment of arterial hypertension].
    Frenţ S; Tudorache V; Ardelean C; Dimitriu D; Lighezan D; Gaiţă D; Mihăicuţă S
    Pneumologia; 2011; 60(4):202-7. PubMed ID: 22420169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension.
    Hermida RC; Ríos MT; Crespo JJ; Moyá A; Domínguez-Sardiña M; Otero A; Sánchez JJ; Mojón A; Fernández JR; Ayala DE;
    Chronobiol Int; 2013 Mar; 30(1-2):192-206. PubMed ID: 23098160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Resistant arterial hypertension].
    Bobrie G; Coville P
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1183-5. PubMed ID: 8572870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Home and ambulatory blood pressure in resistant hypertension.
    Grassi G; Facchetti R; Seravalle G; Cuspidi C; Mancia G
    EuroIntervention; 2013 May; 9 Suppl R():R35-41. PubMed ID: 23732153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistant Hypertension and Chronic Kidney Disease: a Dangerous Liaison.
    Wolley MJ; Stowasser M
    Curr Hypertens Rep; 2016 Apr; 18(5):36. PubMed ID: 27072829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic factors in resistant hypertension: implications for cardiovascular risk stratification and therapeutic management.
    de Souza F; Muxfeldt ES; Salles GF
    Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):735-45. PubMed ID: 22894630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical characteristics of resistant hypertension in renal transplant patients.
    Arias M; Fernández-Fresnedo G; Gago M; Rodrigo E; Gómez-Alamillo C; Toyos C; Allende N
    Nephrol Dial Transplant; 2012 Dec; 27 Suppl 4():iv36-8. PubMed ID: 23258809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistant hypertension? Assessment of adherence by toxicological urine analysis.
    Jung O; Gechter JL; Wunder C; Paulke A; Bartel C; Geiger H; Toennes SW
    J Hypertens; 2013 Apr; 31(4):766-74. PubMed ID: 23337469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistant hypertension in Yaounde.
    Youmbissi TJ; Meli J; Kinkela MN; Ngu JL
    West Afr J Med; 1994; 13(3):175-8. PubMed ID: 7841110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.